Use of rituximab in two unusual antibody-mediated autoimmune disorders.
Adler
Matthew
M
Rheumatology Department, Royal Free Hospital, London NW3 2QG, UK.
Soliotis
Fotini
F
Thakrar
Sonali
S
Stratton
Richard
R
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D000069283:Rituximab; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab